. 2022 Sep 17;11(9):1264. doi: 10.3390/antibiotics11091264

Table 2.

The extended prophylactic effect of bacteriophages with or without encapsulation (n = 10). Challenge with LD₅₀ (a), and LD₁₀₀ (b). The survival rate was observed for 7 days. ^a ND: not done.

(a) LD₅₀ Challenge
Survivability (%)		days post-administration
Survivability (%)		1	3	7	15	28	40	50	60
1st trial	Bacteriophage	70	80	50	30	40	50	50	40
1st trial	PLGA/alginate	90	90	80	70	60	50	50	50
2nd trial	Bacteriophage	80	60	60	50	50	40	50	40
2nd trial	PLGA/alginate	90	80	90	80	70	50	40	50
(b) LD₁₀₀ challenge
Survivability (%)		days post-administration
Survivability (%)		1	3	7	15	28	40	50	60
1st trial	Bacteriophage	80	70	10	10	10	10	ND ^a	ND
1st trial	PLGA/alginate	90	80	80	60	40	0	ND	ND
2nd trial	Bacteriophage	80	10	0	0	10	0	ND	ND
2nd trial	PLGA/alginate	90	90	70	70	30	0	ND	ND